)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Firms term DCGI move 'positive' as it aims at ensuring patient safety
Vault works by inhibiting the production of stomach acid and is approved by the Drugs Controller General of India (DCGI) for the treatment of reflux esophagitis and other acid peptic disorders (APDs)
The average deal size also saw a jump, rising from $9.7 million in Q1 calendar year 2024 to $74 million in Q2 2024
Cipla's share price declined by 0.56 per cent, ending the day's trade at Rs 1,507.50 apiece on the BSE
Analysts predict moderation in growth to 5-7% in FY25
GCPL holds exclusive rights to use Renofluthrin in its products for six to eight years
ICRA also expects the industry to invest Rs 20,000-25,000 crore in FY2025 for capacity expansion and technological advancements
The specific price and date of the offer for sale will likely be announced in the future
Move came a day after UP government waived registration fees on strong hybrid cars
The most popular car models among buyers included the Hyundai Grand i10, Maruti Suzuki Swift, and Baleno
CV sales up, passenger vehicles dip slightly; JLR growth strong
As the monsoon season begins, carmakers and dealers are intensifying their efforts to attract buyers with various incentives, including discounts, exchange bonuses, and assured gifts
KKR's investment aims to support BMH's expansion plans to build a pan-India network of hospitals. This growth will be driven by both organic development and strategic acquisitions
USFDA launches QMM program to reduce drug shortages and improve supply chain issues
IPA bats for Revised Schedule M implementation as key to pharma manufacturing quality in India
The company aims to diversify manufacturing base to enhance proximity to key markets across India and streamline operational costs
The acquisition includes Nicotinell, a global leader in the NRT category, and its local market-leading brand names Nicabate, Habitrol, and Thrive
The company envisions EV-2W category will maintain a 60 per cent market share by 2030, with the RUV category capturing around 25 to 30 per cent of the market
Price rise would be upto Rs 1500 varying with models
The company aims to produce 1 million e-axles per year by 2030 to accelerate India's transition to green mobility